STUDY WARNS OF SERIOUS ADVERSE EVENTS FOLLOWING COVID VACCINE INJECTION

1 view
Skip to first unread message

Harold Saive

unread,
Sep 1, 2022, 12:30:41 PMSep 1
to TownSquareNews

STUDY WARNS OF SERIOUS ADVERSE EVENTS FOLLOWING COVID VACCINE INJECTION

A study published yesterday in the journal Vaccine titled “Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults.”

The researchers used Pfizer and Moderna’s own randomized, placebo-controlled trials and compared them against an industry list of common adverse events following vaccination. Guess what they found?

Combined, there was a 16% higher risk of serious adverse events in mRNA vaccine recipients … points to the need for formal harm-benefit analyses … release of participant level datasets… The Pfizer trial exhibited a 36% higher risk of serious adverse events in the vaccine group[.]
That’s not good for business.

You can add this study to the ever-growing list of journal articles critical of the jabs. Remember: jab-critical studies have been embargoed until just recently; journal editors have simply refused to print them because they “could cause vaccine hesitancy.”

Something is changing.

Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults
https://www.sciencedirect.com/science/article/pii/S0264410X22010283

Abstract
Introduction
In 2020, prior to COVID-19 vaccine rollout, the Brighton Collaboration created a priority list, endorsed by the World Health Organization, of potential adverse events relevant to COVID-19 vaccines. We adapted the Brighton Collaboration list to evaluate serious adverse events of special interest observed in mRNA COVID-19 vaccine trials.

Methods
Secondary analysis of serious adverse events reported in the placebo-controlled, phase III randomized clinical trials of Pfizer and Moderna mRNA COVID-19 vaccines in adults (NCT04368728 and NCT04470427), focusing analysis on Brighton Collaboration adverse events of special interest.

Results
Pfizer and Moderna mRNA COVID-19 vaccines were associated with an excess risk of serious adverse events of special interest of 10.1 and 15.1 per 10,000 vaccinated over placebo baselines of 17.6 and 42.2 (95 % CI −0.4 to 20.6 and −3.6 to 33.8), respectively. Combined, the mRNA vaccines were associated with an excess risk of serious adverse events of special interest of 12.5 per 10,000 vaccinated (95 % CI 2.1 to 22.9); risk ratio 1.43 (95 % CI 1.07 to 1.92). The Pfizer trial exhibited a 36 % higher risk of serious adverse events in the vaccine group; risk difference 18.0 per 10,000 vaccinated (95 % CI 1.2 to 34.9); risk ratio 1.36 (95 % CI 1.02 to 1.83). The Moderna trial exhibited a 6 % higher risk of serious adverse events in the vaccine group: risk difference 7.1 per 10,000 (95 % CI –23.2 to 37.4); risk ratio 1.06 (95 % CI 0.84 to 1.33). Combined, there was a 16 % higher risk of serious adverse events in mRNA vaccine recipients: risk difference 13.2 (95 % CI −3.2 to 29.6); risk ratio 1.16 (95 % CI 0.97 to 1.39).


--
See TOWN SQUARE NEWS Updates: https://groups.google.com/g/town-square-news

 width=Virus-free.www.avg.com
Reply all
Reply to author
Forward
0 new messages